Plans spiked

"Our strategy has not changed. We want to remain a regional player and strengthen our position on the CEE markets. We are negotiating the purchase of a few foreign entities," Polpharma president, Jacek Glinka, commented. In 2005 the firm will introduce up to seven new medicines to the market.